Nomura Asset Management CO LTD Clovis Oncology, Inc. Transaction History

Nomura Asset Management CO LTD

5 transactions

Quarter	Operation	Price Per share	shares change
Q3 2018 Nov 07, 2018	SELL	$29.37 - $49.48 $0 - $0	0 Closed
Q2 2018 Aug 03, 2018	BUY	$42.06 - $62.4 $0 - $0	0 New
Q1 2018 May 14, 2018	BUY	$50.12 - $67.72 $0 - $0	0 New
Q4 2017 Feb 14, 2018	BUY	$57.69 - $84.58 $0 - $0	0 New
Q3 2017 Nov 13, 2017	BUY	$67.17 - $84.81 $0 - $0	0

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

Stay updated on Nomura Asset Management CO LTD with notifications on news.